Davion Healthcare Plc filed a Form 6-K with the SEC on November 20, 2026, reporting that Glenn Williams has stepped down as Chief Executive Officer and that founder Jack Kaye has assumed the role of Interim Chief Executive Officer with immediate effect.

Key Highlights

  • CEO departure: Glenn Williams has stepped down as Chief Executive Officer, according to the filing.
  • Interim leadership: Jack Kaye, the company's founder and Executive Chairman, has assumed the additional role of Interim Chief Executive Officer with immediate effect.
  • Prior role: Jack Kaye previously served as the company's Chief Executive Officer before his current Executive Chairman position, the filing disclosed.
  • Strategy unchanged: The filing states that "the Company's business strategy and operational priorities remain unchanged."
  • Continuing focus: According to the filing, Kaye will continue to lead the company's "strategic development and acquisition programme across North America and Europe."

Leadership Transition at Davion Healthcare Plc

Davion Healthcare Plc (NASDAQ:DAVI), a foreign private issuer incorporated in Ireland, disclosed a change in its chief executive leadership in a report covering the month of November 2026. The company reported that Glenn Williams has stepped down from the CEO position, with no additional details regarding the circumstances of his departure provided in the filing.

Jack Kaye, identified in the filing as the company's founder and Executive Chairman and as its former Chief Executive Officer, has taken on the Interim Chief Executive Officer role in addition to his existing responsibilities. The filing states the transition took effect immediately. The document was signed by Kaye in his capacity as Executive Chairman and dated November 20, 2026.

The company disclosed that Kaye will continue overseeing its "strategic development and acquisition programme across North America and Europe." The filing explicitly noted that the company's business strategy and operational priorities remain unchanged following the leadership transition. No information regarding a permanent CEO search, compensation arrangements, or any other personnel changes was included in the filing.

What Was Disclosed

Davion Healthcare Plc disclosed the departure of CEO Glenn Williams and the appointment of founder and Executive Chairman Jack Kaye as Interim Chief Executive Officer, effective immediately, with the company stating its strategy and operational priorities are unchanged.